NCT06171386 Microneedling vs Dermabrasion for Early Facial Scar Resurfacing
| NCT ID | NCT06171386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Scar |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-04-01 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine whether microneedling or dermabrasion in the early post-operative period is superior in improving the appearance of surgical scars on the face.
Eligibility Criteria
Inclusion Criteria: * Volunteer adult patients will be identified by visiting the Facial Plastics and Reconstructive Surgery Clinic at Atrium Health Wake Forest Baptist. * Patients will be 18 years old+ and have a vertical surgical scar in the superior 1/3 of the face (trichion to glabella). * Patients will enroll in the clinic research registry and indicate an interest in being involved in the study. Exclusion Criteria: * Patients who rate Types 4-6 on the Fitzpatrick scale will be excluded due to risk of poor outcome from dermabrasion. * There are no other planned exclusion criteria. Patients will not be excluded on the basis of gender, race/ethnicity, or age, provided that they meet the described inclusion criteria.
Contact & Investigator
Candace M Water, MD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT06171386 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Scar. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06171386 currently recruiting?
Yes, NCT06171386 is actively recruiting participants. Contact the research team at cmwaters@wakehealth.edu for enrollment information.
Where is the NCT06171386 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT06171386 clinical trial?
NCT06171386 is sponsored by Wake Forest University Health Sciences. The principal investigator is Candace M Water, MD at Wake Forest University Health Sciences. The trial plans to enroll 30 participants.